BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24458713)

  • 21. 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids.
    Sapieha P; Stahl A; Chen J; Seaward MR; Willett KL; Krah NM; Dennison RJ; Connor KM; Aderman CM; Liclican E; Carughi A; Perelman D; Kanaoka Y; Sangiovanni JP; Gronert K; Smith LE
    Sci Transl Med; 2011 Feb; 3(69):69ra12. PubMed ID: 21307302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart.
    Anwar-Mohamed A; El-Sherbeni AA; Kim SH; Althurwi HN; Zordoky BN; El-Kadi AO
    Xenobiotica; 2012 Dec; 42(12):1235-47. PubMed ID: 22680237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis.
    Zhang G; Panigrahy D; Mahakian LM; Yang J; Liu JY; Stephen Lee KS; Wettersten HI; Ulu A; Hu X; Tam S; Hwang SH; Ingham ES; Kieran MW; Weiss RH; Ferrara KW; Hammock BD
    Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6530-5. PubMed ID: 23553837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms.
    Enayetallah AE; French RA; Grant DF
    J Mol Histol; 2006 May; 37(3-4):133-41. PubMed ID: 16957870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
    Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
    Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.
    Dreisbach AW; Japa S; Sigel A; Parenti MB; Hess AE; Srinouanprachanh SL; Rettie AE; Kim H; Farin FM; Hamm LL; Lertora JJ
    Am J Hypertens; 2005 Oct; 18(10):1276-81. PubMed ID: 16202848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Individual Circulating FFAs on Plasma and Hepatic FFA Epoxides, Diols, and Epoxide-Diol Ratios as Indices of Soluble Epoxide Hydrolase Activity.
    Oh YT; Yang J; Morisseau C; He Q; Hammock B; Youn JH
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium.
    Jia J; Davis CM; Zhang W; Edin ML; Jouihan S; Jia T; Bradbury JA; Graves JP; DeGraff LM; Lee CR; Ronnekleiv O; Wang R; Xu Y; Zeldin DC; Alkayed NJ
    Exp Neurol; 2016 May; 279():75-85. PubMed ID: 26902473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy.
    Hu J; Dziumbla S; Lin J; Bibli SI; Zukunft S; de Mos J; Awwad K; Frömel T; Jungmann A; Devraj K; Cheng Z; Wang L; Fauser S; Eberhart CG; Sodhi A; Hammock BD; Liebner S; Müller OJ; Glaubitz C; Hammes HP; Popp R; Fleming I
    Nature; 2017 Dec; 552(7684):248-252. PubMed ID: 29211719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Consequences of Soluble Epoxide Hydrolase Deletion on Tumorigenesis and Metastasis in a Mouse Model of Breast Cancer.
    Kesavan R; Frömel T; Zukunft S; Brüne B; Weigert A; Wittig I; Popp R; Fleming I
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
    López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily.
    Barbosa-Sicard E; Markovic M; Honeck H; Christ B; Muller DN; Schunck WH
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1275-81. PubMed ID: 15766564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Lipid Mediators in Retinal Angiogenesis and Retinopathy.
    Fleming I
    Front Pharmacol; 2019; 10():739. PubMed ID: 31333461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.
    Ulu A; Harris TR; Morisseau C; Miyabe C; Inoue H; Schuster G; Dong H; Iosif AM; Liu JY; Weiss RH; Chiamvimonvat N; Imig JD; Hammock BD
    J Cardiovasc Pharmacol; 2013 Sep; 62(3):285-97. PubMed ID: 23676336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids.
    Arnold C; Konkel A; Fischer R; Schunck WH
    Pharmacol Rep; 2010; 62(3):536-47. PubMed ID: 20631419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The profile of urinary lipid metabolites in cats.
    Kobayashi Y; Nakamura T; Kobayashi K; Murata T
    J Vet Med Sci; 2020 Jul; 82(7):1017-1020. PubMed ID: 32507833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.
    Frömel T; Hu J; Fleming I
    Adv Pharmacol; 2023; 97():327-373. PubMed ID: 37236763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
    Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model.
    Liu JY; Yang J; Inceoglu B; Qiu H; Ulu A; Hwang SH; Chiamvimonvat N; Hammock BD
    Biochem Pharmacol; 2010 Mar; 79(6):880-7. PubMed ID: 19896470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chiral lipidomics of monoepoxy and monohydroxy metabolites derived from long-chain polyunsaturated fatty acids.
    Blum M; Dogan I; Karber M; Rothe M; Schunck WH
    J Lipid Res; 2019 Jan; 60(1):135-148. PubMed ID: 30409844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.